Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting
Abstract Background Information is lacking from real‐life studies evaluating the efficacy of tildrakizumab in moderate‐to‐severe psoriasis. Materials and Methods We retrospectively analysed a database of 30 patients with moderate‐to‐severe psoriasis (PsO) that were treated with tildrakizumab (100 mg...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
Wiley,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |